Mr. Jim Durward reports

NDATALYZE CORP. ANNOUNCES ADOPTION OF SEMI-ANNUAL FINANCIAL REPORTING TRIAL, PROVIDES A PROGRESS REPORT ON THE POTENTIAL RTO, AND UPDATES THE EPITOME SPORTS PERFORMANCE ASSESSMENT PROJECT

Ndatalyze Corp. intends to participate in the semi-annual reporting (SAR) pilot program recently adopted by the Canadian Securities Administrators (CSA), has provided a progress report on the potential RTO and has updated the Epitome sports performance assessment project.

The SAR pilot: Implemented through Coordinated Blanket Order 51-933, the pilot allows eligible venture issuers listed on the Canadian Securities Exchange (CSE) to voluntarily move from a quarterly to a semi-annual financial reporting framework. By adopting the SAR, Ndatalyze aims to reduce the administrative and financial burden associated with quarterly reporting, allowing management to focus more resources on its core technology-driven mental health solutions.

Transition details -- Ndatalyze's fiscal year ends on Feb. 28. Under the SAR pilot, the company will be exempt from filing interim financial reports and related management's discussion and analysis (MD&A) for its first and third quarters.

• Initial interim period: The company will not file an interim report for the first quarter (Q1) ending May 31, 2026.
• Continuing reporting: Ndatalyze will continue to file audited annual financial statements (due within 120 days of Feb. 28) and six-month interim financial reports (due within 60 days of Aug. 31).
• Continued disclosure: The company remains committed to timely disclosure and will continue to report all material changes and significant developments as required under National Instrument 51-102.

Eligibility -- Ndatalyze confirms it meets the pilot program's eligibility criteria, which include being a venture issuer with annual revenues of less than $10-million and maintaining a clean 12-month continuous disclosure record.

RTO (reverse takeover) update: The company has been informed by the RTO target, Prism Diversified Ltd., that its pre-RTO financing is proceeding and that it expects to be in a position to execute a definitive agreement in the near future. Based on the Prism report, the company feels confident that the RTO will proceed.

The Epitome sports performance assessment project: The commercialization report is now complete. This report was meant to inform the marketing approach and involved executive-level input from three highly regarded hockey schools/academies, those being ALPS Hockey Academy (Italy), MacLauchlan College (Canada) and Okanagan Hockey (Canada). As a result of the feedback, the company is confident in the priority order of Epitome's target markets, the classification of person (scout, coach, JV partner) who is best positioned to penetrate those markets, what the pricing/pricing structure needs to include and the seasonality of the sales cycle. With these data in hand, the company is now considering its commercialization options and will report as things progress.

About Ndatalyze Corp.

Ndatalyze generates technology-based, health/performance-related solutions using advanced AI (artificial intelligence) and biometric data analysis.

We seek Safe Harbor.